In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.

The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.

In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.

According to the government, Tina Ball and her lab company knowingly billed North Carolina Medicaid for urine drug tests that were medically unnecessary.

The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.

Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.

Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.

Aspira can now offer the test, intended for assessing ovarian cancer risk in women with an adnexal mass, to patients in New York state.

Retirements and the outcomes of a handful of close races could reshape congressional committees tasked with oversight of issues important to labs.

The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.

NEW YORK – BioMérieux announced on Tuesday that it has obtained the CE mark for an assay to detect vitamin B12. The automated, quantitative test runs on the firm's Vidas immunoanalyzers.

Last week, readers were most interested in a story about Roche and BARDA teaming up to develop diagnostic tests for traumatic brain injuries.